Boston Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Boston Medical Center sits in the top decile of US sponsors by registered trial count (#130 of 15,742 sponsors by registered trial count).

253 total trials 28 currently recruiting 177 completed early-phase tilt top decile by trial count

Boston Medical Center: 253 sponsored US clinical trials, 28 recruiting.

Boston Medical Center sponsors 253 registered US clinical trials on ClinicalTrials.gov, 28 of them currently recruiting, and 177 completed. 18 of these trials are in Phase 3-4 (later-stage) and 47 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 5 trials.

Top-decile sponsor footprint

Boston Medical Center ranks in the top decile of sponsors by registered trial count (#130 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 48/100

177 of 212 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

253 total, page 5 of 6

COMPLETED Phase 1

Stereotactic Radiosurgery in Treating Patients With Spinal Metastases

NCT00853528

TERMINATED NA

Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

NCT00852644

COMPLETED NA

Improving Dietary Behavior Through Tailored Messages

NCT01864694

COMPLETED NA

Problem Solving Education and Neonatal Intensive Care Unit (NICU) Mothers

NCT01214967

COMPLETED NA

Educational and Supportive Interventions to Prevent Cardiopulmonary Rehospitalization

NCT00217867

COMPLETED

Study of Sacral Fractures Using Patient Based and Objective Outcomes

NCT00798733

COMPLETED NA

Study of PhoneCare System to Treat Patients With Chronic Diseases

NCT01458184

COMPLETED Phase 3

Effects of the Atkins Diet Versus a Low Fat Diet on Inflammation

NCT00993278

COMPLETED NA

A Multicenter Randomized Trial Comparing Antiglide and Lateral Plate Fixation in Ankle Fractures

NCT00718302

COMPLETED Phase 2

Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

NCT00790647

COMPLETED Phase 2

Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

NCT00679367

COMPLETED NA

Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients

NCT00629265

COMPLETED

Clinical Outcomes Following Glenoid Neck Fracture as Correlated With Quantitative Assessment of Osseous Injury

NCT00644813

COMPLETED

Novel Biophotonics Methodology for Colon Cancer Screening

NCT01999478

TERMINATED NA

Clinical Trial of a Computer-driven Weaning System for Patients Requiring Mechanical Ventilation

NCT00606554

COMPLETED Phase 2

Conversational IT for Better, Safer Pediatric Primary Care

NCT01188629

COMPLETED NA

Automated Assessment of Mental Health in the Workplace

NCT00134576

COMPLETED Phase 2

Improving HIV Prevention Skills in People With Serious Mental Illnesses

NCT00356291

COMPLETED Phase 2

Yoga for Chronic Low Back Pain

NCT00865358

COMPLETED NA

A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Proximal Tibial Fractures

NCT00429585

COMPLETED NA

A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Distal Femur Fractures

NCT00429663

COMPLETED

Anal HPV Infection and Abnormal Cytology in HIV-infected Women

NCT00933140

TERMINATED Phase 2

HD Melphalan and SCT in Patients With IGDD or LCDD

NCT00681044

COMPLETED Phase 3

Addiction Health Evaluation And Disease Management (AHEAD) Study

NCT00278447

COMPLETED NA

Improving Bowel Preparation for Colonoscopy With a Simple Educational Card

NCT00643682

COMPLETED Phase 2

HIV Prevention With the Mentally Ill

NCT00643305

COMPLETED Phase 4

Patient Navigation in the Safety Net:CONNECTeDD

NCT00613275

COMPLETED Phase 2

IT-Supported Early Treatment Of Childhood Overweight

NCT01188616

COMPLETED

The Development and Testing of an Electronic Tool to Measure Physical Activity in Domestic Settings

NCT00207181

TERMINATED Phase 4

TOM: Testosterone in Older Men With Sarcopenia

NCT00240981

COMPLETED Phase 3

Brief Intervention to Reduce STDs in ER Drug Users

NCT01379599

COMPLETED Phase 1

Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)

NCT00183118

COMPLETED Phase 2

The iHealth Study in College Students

NCT00183131

COMPLETED Phase 1

Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients

NCT00207233

TERMINATED Phase 1

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

NCT00100971

COMPLETED Phase 2

Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care

NCT00332514

TERMINATED

A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients

NCT00207389

COMPLETED NA

Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence

NCT00201149

COMPLETED Phase 2

Psychosocial and Medication Treatment for Anxiety in Alcoholism

NCT00248612

COMPLETED Phase 1

Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic Control

NCT00207207

COMPLETED NA

Use of MCT Oil for Enhancement of Weight Loss in Obese Patients

NCT00207272

COMPLETED Phase 1

Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents

NCT00207519

COMPLETED NA

Automated Telephone System to Improve Treatment Adherence in People With Depression

NCT00136240

COMPLETED

Regression Discontinuity Design to Evaluate of Drotrecogin Alpha Effectiveness

NCT02843685

COMPLETED NA

Interactive Multirisk-Factor Intervention for Hypertension (HTN) Blacks

NCT00207194

TERMINATED Phase 2

2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

NCT00075608

COMPLETED Phase 3

ASAP Study - Hospital-Based Brief Intervention for Alcohol Problems

NCT00183105

COMPLETED Phase 2

Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis

NCT00075621

COMPLETED Phase 1

Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia

NCT00006097

COMPLETED Phase 1

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

NCT00003005

← Previous Page 5 of 6 Next →

Phase Distribution

PhaseTrial count
Phase 1 23
Phase 2 24
Phase 3 9
Phase 4 9

What is open in the Boston Medical Center pipeline

28 recruiting of 253 indexed (11% open); 177 completed (70%).

Phase mix: 18 late (III/IV) vs 47 early (I/II) (early-phase heavy).

Top condition: Opioid Use Disorder (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Boston Medical Center: open-pipeline peers nationwide

Peers matched on 253 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Boston Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300 10%15%20%25% Total trials Recruiting share Boston Medical CenterUniversity of South FloridaUniversity of Texas at AustinMasonic Cancer Center, University of MinnesotaPennington Biomedical Research CenterThe Miriam HospitalADC Therapeutics S.A.Adrian VellaAIDS Malignancy Consortium
Boston Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Boston Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 253 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this Boston Medical Center page

253 registered trials is a research-attention snapshot, not an endorsement of Boston Medical Center or any single study.

  • 28 of Boston Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Opioid Use Disorder is the condition Boston Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Boston Medical Center pipeline card: 253 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.